Computational Studies Devoted to the Catalytic Mechanism of Threonine Aldolase, a Critical Enzyme in the Pharmaceutical Industry to Synthesize β-Hydroxy-α-amino Acids

IF 13.6 1区 化学 Q1 CHEMISTRY, PHYSICAL
Juliana F. Rocha, Sérgio F. Sousa and Nuno M. F. Sousa A. Cerqueira*, 
{"title":"Computational Studies Devoted to the Catalytic Mechanism of Threonine Aldolase, a Critical Enzyme in the Pharmaceutical Industry to Synthesize β-Hydroxy-α-amino Acids","authors":"Juliana F. Rocha,&nbsp;Sérgio F. Sousa and Nuno M. F. Sousa A. Cerqueira*,&nbsp;","doi":"10.1021/acscatal.1c05567","DOIUrl":null,"url":null,"abstract":"<p >The catalytic mechanism of threonine aldolase (TA) was herein studied in atomic detail employing the computational ONIOM hybrid QM/MM methodology. TA is a PLP-dependent enzyme that catalyzes the retro-aldol cleavage of threonine into glycine and acetaldehyde, as well as the reverse reaction. This enzyme is currently seen as the optimal approach for the regioselective synthesis of β-hydroxy-α-amino acids (HAAs), which are very difficult to obtain by standard methods. The results obtained herein show that the catalytic mechanism of TA occurs in three steps: (i) deprotonation of the hydroxyl group of EA1, (ii) covalent bond cleavage, and (iii) hydrolysis. According to the Gibbs free energy profile, the rate-limiting step of the catalytic process is the covalent bond cleavage, which results in the formation of acetaldehyde. The calculated energy barrier for this step is 16.7 kcal mol<sup>–1</sup>, which agrees very well with the kinetic data available in the literature (17.4 kcal mol<sup>–1</sup>). All these results can now be used for the optimization of the synthesis of HAAs that serve as building blocks of several commercial drugs, such as antibiotics, immunosuppressants, and the anti-Parkinson’s disease drug <span>l</span>-<i>threo</i>-3,4-dihydroxyphenylserine.</p>","PeriodicalId":9,"journal":{"name":"ACS Catalysis ","volume":"12 9","pages":"4990–4999"},"PeriodicalIF":13.6000,"publicationDate":"2022-04-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"ACS Catalysis ","FirstCategoryId":"92","ListUrlMain":"https://pubs.acs.org/doi/10.1021/acscatal.1c05567","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, PHYSICAL","Score":null,"Total":0}
引用次数: 2

Abstract

The catalytic mechanism of threonine aldolase (TA) was herein studied in atomic detail employing the computational ONIOM hybrid QM/MM methodology. TA is a PLP-dependent enzyme that catalyzes the retro-aldol cleavage of threonine into glycine and acetaldehyde, as well as the reverse reaction. This enzyme is currently seen as the optimal approach for the regioselective synthesis of β-hydroxy-α-amino acids (HAAs), which are very difficult to obtain by standard methods. The results obtained herein show that the catalytic mechanism of TA occurs in three steps: (i) deprotonation of the hydroxyl group of EA1, (ii) covalent bond cleavage, and (iii) hydrolysis. According to the Gibbs free energy profile, the rate-limiting step of the catalytic process is the covalent bond cleavage, which results in the formation of acetaldehyde. The calculated energy barrier for this step is 16.7 kcal mol–1, which agrees very well with the kinetic data available in the literature (17.4 kcal mol–1). All these results can now be used for the optimization of the synthesis of HAAs that serve as building blocks of several commercial drugs, such as antibiotics, immunosuppressants, and the anti-Parkinson’s disease drug l-threo-3,4-dihydroxyphenylserine.

Abstract Image

苏氨酸醛缩酶催化合成β-羟基-α-氨基酸的计算研究
本文采用计算型niom混合QM/MM方法对苏氨酸醛缩酶(TA)的催化机理进行了原子细节研究。TA是一种plp依赖性酶,可催化苏氨酸的反醛醇裂解成甘氨酸和乙醛,以及逆向反应。该酶目前被认为是区域选择性合成β-羟基-α-氨基酸(HAAs)的最佳途径,这种酶很难通过标准方法获得。结果表明,TA的催化机理分为三个步骤:(i) EA1羟基去质子化,(ii)共价键断裂,(iii)水解。根据吉布斯自由能谱,催化过程的限速步骤是共价键的裂解,从而导致乙醛的形成。这一步骤的能垒计算值为16.7 kcal mol-1,与文献中的动力学数据(17.4 kcal mol-1)非常吻合。所有这些结果现在都可以用于优化HAAs的合成,这些HAAs可以作为几种商业药物的基础,如抗生素、免疫抑制剂和抗帕金森病药物l-threo-3,4-二羟基苯基丝氨酸。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
ACS Catalysis
ACS Catalysis CHEMISTRY, PHYSICAL-
CiteScore
20.80
自引率
6.20%
发文量
1253
审稿时长
1.5 months
期刊介绍: ACS Catalysis is an esteemed journal that publishes original research in the fields of heterogeneous catalysis, molecular catalysis, and biocatalysis. It offers broad coverage across diverse areas such as life sciences, organometallics and synthesis, photochemistry and electrochemistry, drug discovery and synthesis, materials science, environmental protection, polymer discovery and synthesis, and energy and fuels. The scope of the journal is to showcase innovative work in various aspects of catalysis. This includes new reactions and novel synthetic approaches utilizing known catalysts, the discovery or modification of new catalysts, elucidation of catalytic mechanisms through cutting-edge investigations, practical enhancements of existing processes, as well as conceptual advances in the field. Contributions to ACS Catalysis can encompass both experimental and theoretical research focused on catalytic molecules, macromolecules, and materials that exhibit catalytic turnover.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书